A portable, disposable, and home self-applied transcutaneous electrical nerve stimulation (TENS) device is effective for reducing pain among patients with migraine.
Study researchers evaluated the potential of osmophobia in as a clinical diagnostic marker of migraine in children and adolescents.
Migraine may be more common in people with rosacea.
Interventions that increase dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), with or without a decrease in linoleic acid, alter bioactive mediators that are implicated in migraine and reduce headaches, but they do not improve headache-related quality of life.
The aim of the study was to assess the benefits and risks associated with various acute treatments for episodic migraine.
COVID-19 quarantine had a positive impact on migraine.
The researchers’ goal was to weigh the risks and benefits of acute treatments for episodic migraine in adults.
Pregnant women with migraine are at increased risk of having obstetric and medical complications compared to women without migraine.
The researchers’ goal was to evaluate whether the 15-day threshold of headache days per month reflects significant differences in disability across the migraine and its spectrum.
Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.